Cargando…

Plasmodium falciparum resistance to ACTs: Emergence, mechanisms, and outlook

Emergence and spread of resistance in Plasmodium falciparum to the frontline treatment artemisinin-based combination therapies (ACTs) in the epicenter of multidrug resistance of Southeast Asia threaten global malaria control and elimination. Artemisinin (ART) resistance (or tolerance) is defined cli...

Descripción completa

Detalles Bibliográficos
Autores principales: Siddiqui, Faiza Amber, Liang, Xiaoying, Cui, Liwang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8188179/
https://www.ncbi.nlm.nih.gov/pubmed/34090067
http://dx.doi.org/10.1016/j.ijpddr.2021.05.007
_version_ 1783705286918275072
author Siddiqui, Faiza Amber
Liang, Xiaoying
Cui, Liwang
author_facet Siddiqui, Faiza Amber
Liang, Xiaoying
Cui, Liwang
author_sort Siddiqui, Faiza Amber
collection PubMed
description Emergence and spread of resistance in Plasmodium falciparum to the frontline treatment artemisinin-based combination therapies (ACTs) in the epicenter of multidrug resistance of Southeast Asia threaten global malaria control and elimination. Artemisinin (ART) resistance (or tolerance) is defined clinically as delayed parasite clearance after treatment with an ART drug. The resistance phenotype is restricted to the early ring stage and can be measured in vitro using a ring-stage survival assay. ART resistance is associated with mutations in the propeller domain of the Kelch family protein K13. As a pro-drug, ART is activated primarily by heme, which is mainly derived from hemoglobin digestion in the food vacuole. Activated ARTs can react promiscuously with a wide range of cellular targets, disrupting cellular protein homeostasis. Consistent with this mode of action for ARTs, the molecular mechanisms of K13-mediated ART resistance involve reduced hemoglobin uptake/digestion and increased cellular stress response. Mutations in other genes such as AP-2μ (adaptor protein-2 μ subunit), UBP-1 (ubiquitin-binding protein-1), and Falcipain 2a that interfere with hemoglobin uptake and digestion also increase resistance to ARTs. ART resistance has facilitated the development of resistance to the partner drugs, resulting in rapidly declining ACT efficacies. The molecular markers for resistance to the partner drugs are mostly associated with point mutations in the two food vacuole membrane transporters PfCRT and PfMDR1, and amplification of pfmdr1 and the two aspartic protease genes plasmepsin 2 and 3. It has been observed that mutations in these genes can have opposing effects on sensitivities to different partner drugs, which serve as the principle for designing triple ACTs and drug rotation. Although clinical ACT resistance is restricted to Southeast Asia, surveillance for drug resistance using in vivo clinical efficacy, in vitro assays, and molecular approaches is required to prevent or slow down the spread of resistant parasites.
format Online
Article
Text
id pubmed-8188179
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-81881792021-06-16 Plasmodium falciparum resistance to ACTs: Emergence, mechanisms, and outlook Siddiqui, Faiza Amber Liang, Xiaoying Cui, Liwang Int J Parasitol Drugs Drug Resist Special issue articles on 'Drug Resistance - Mechanisms, Surveillance and Parasite Populations' Emergence and spread of resistance in Plasmodium falciparum to the frontline treatment artemisinin-based combination therapies (ACTs) in the epicenter of multidrug resistance of Southeast Asia threaten global malaria control and elimination. Artemisinin (ART) resistance (or tolerance) is defined clinically as delayed parasite clearance after treatment with an ART drug. The resistance phenotype is restricted to the early ring stage and can be measured in vitro using a ring-stage survival assay. ART resistance is associated with mutations in the propeller domain of the Kelch family protein K13. As a pro-drug, ART is activated primarily by heme, which is mainly derived from hemoglobin digestion in the food vacuole. Activated ARTs can react promiscuously with a wide range of cellular targets, disrupting cellular protein homeostasis. Consistent with this mode of action for ARTs, the molecular mechanisms of K13-mediated ART resistance involve reduced hemoglobin uptake/digestion and increased cellular stress response. Mutations in other genes such as AP-2μ (adaptor protein-2 μ subunit), UBP-1 (ubiquitin-binding protein-1), and Falcipain 2a that interfere with hemoglobin uptake and digestion also increase resistance to ARTs. ART resistance has facilitated the development of resistance to the partner drugs, resulting in rapidly declining ACT efficacies. The molecular markers for resistance to the partner drugs are mostly associated with point mutations in the two food vacuole membrane transporters PfCRT and PfMDR1, and amplification of pfmdr1 and the two aspartic protease genes plasmepsin 2 and 3. It has been observed that mutations in these genes can have opposing effects on sensitivities to different partner drugs, which serve as the principle for designing triple ACTs and drug rotation. Although clinical ACT resistance is restricted to Southeast Asia, surveillance for drug resistance using in vivo clinical efficacy, in vitro assays, and molecular approaches is required to prevent or slow down the spread of resistant parasites. Elsevier 2021-05-26 /pmc/articles/PMC8188179/ /pubmed/34090067 http://dx.doi.org/10.1016/j.ijpddr.2021.05.007 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Special issue articles on 'Drug Resistance - Mechanisms, Surveillance and Parasite Populations'
Siddiqui, Faiza Amber
Liang, Xiaoying
Cui, Liwang
Plasmodium falciparum resistance to ACTs: Emergence, mechanisms, and outlook
title Plasmodium falciparum resistance to ACTs: Emergence, mechanisms, and outlook
title_full Plasmodium falciparum resistance to ACTs: Emergence, mechanisms, and outlook
title_fullStr Plasmodium falciparum resistance to ACTs: Emergence, mechanisms, and outlook
title_full_unstemmed Plasmodium falciparum resistance to ACTs: Emergence, mechanisms, and outlook
title_short Plasmodium falciparum resistance to ACTs: Emergence, mechanisms, and outlook
title_sort plasmodium falciparum resistance to acts: emergence, mechanisms, and outlook
topic Special issue articles on 'Drug Resistance - Mechanisms, Surveillance and Parasite Populations'
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8188179/
https://www.ncbi.nlm.nih.gov/pubmed/34090067
http://dx.doi.org/10.1016/j.ijpddr.2021.05.007
work_keys_str_mv AT siddiquifaizaamber plasmodiumfalciparumresistancetoactsemergencemechanismsandoutlook
AT liangxiaoying plasmodiumfalciparumresistancetoactsemergencemechanismsandoutlook
AT cuiliwang plasmodiumfalciparumresistancetoactsemergencemechanismsandoutlook